{"id":"W2103257412","doi":"10.1200/jco.2005.07.757","title":"Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1854,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinblastine; Gemcitabine; Internal medicine; Transitional cell carcinoma; Hazard ratio; Cisplatin; Bladder cancer; Urology; Oncology; Methotrexate; Chemotherapy; Doxorubicin; Antimetabolite; Progression-free survival; Gastroenterology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003043329,0.0008680269,0.001827206,0.0002922046,0.0003853238,0.000979998,0.0006171871,0.001440414,0.002462124],"category_scores_gemma":[0.00346346,0.0004281078,0.002420832,0.0003001058,0.0007944563,0.0007929455,0.0004048211,0.00240788,0.000300066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001111477,"about_ca_system_score_gemma":0.001087805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007310295,"about_ca_topic_score_gemma":0.001965514,"domain_scores_codex":[0.9981474,0.00135245,0.0001204657,0.0001859684,0.00008012372,0.0001137727],"domain_scores_gemma":[0.9975044,0.0009711172,0.0006778459,0.0001390212,0.0001097081,0.0005979434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9825565,0.002501072,0.001637439,0.0003268479,0.001633352,0.00002297127,0.00002847982,0.0005207606,0.000859187,0.00003492657,0.0002396615,0.009638892],"study_design_scores_gemma":[0.8860928,0.1021277,0.007282881,0.00007755151,0.002596631,0.00005033808,0.0000239682,0.0007603118,0.0004030885,0.000127669,0.0004396329,0.00001738221],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930079,0.004939945,0.0002239018,0.0004366622,0.0002263126,0.0004905653,0.0001980288,0.00001734971,0.0004592475],"genre_scores_gemma":[0.9965616,0.001228222,0.0003586896,0.0004441883,0.0001926542,0.0004841783,0.0003665687,0.000005326459,0.000358518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003043329,"threshold_uncertainty_score":0.0160948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08192046514609955,"score_gpt":0.4237490158951968,"score_spread":0.3418285507490972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}